Funding for neglected diseases
Global funding for research and product development for neglected diseases reached a record high of $4.0 billion in 2018 according to the 2019 G-FINDER survey, which reports on global investment in research and development for neglected diseases, including human immunodeficiency virus (HIV), tuberculosis and malaria.
As in previous years, HIV, tuberculosis and malaria collectively received more than two thirds ($2.8 billion, 69%) of all global funding for neglected disease research and development.
http://go.aws/2ugoFtw
Looking ahead
2 – 6 March. United Nations Commission on Narcotic Drugs, Vienna, Austria.
4 – 5 March. The WHO Symposium on the Future of Digital Health Systems in the European Region, Copenhagen, Denmark.
9 –11 March. Global Alcohol Policy Conference, Dublin, Ireland.